Aarti Drugs has received an approval for the proposed scheme of amalgamation of Suyash Laboratories with Aarti Drugs, subject to such requisite approvals including shareholders, and High Court. The company has received an approval at its board meeting held on July 29, 2011. The appointed date for the said amalgamation has been fixed as April 01, 2011.
Further, since Suyash Laboratories, is a wholly owned subsidiary of Aarti Drugs, no equity shares would be required to be issued by the company on account of the said amalgamation.
Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1779.40 |
| Dr. Reddys Lab | 1268.75 |
| Cipla | 1376.75 |
| Zydus Lifesciences | 1105.75 |
| Lupin | 2263.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: